Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673994 · ClinicalTrials.gov registry record
Blood Flow Response and Acute INterval Exercise
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 91
- Enrollment target
NCT04673994 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 91 participants.
The verdict
NCT04673994 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
The objective of this project is to study the cerebrovascular response to a single bout of high intensity interval exercise (HIIT) in 25 individuals with chronic stroke compared to 25 age- and sex- matched healthy controls (CON). We will enroll 25 young healthy adults (CONyoung) as a reference group. Our hypothesis is that the cerebrovascular response in individuals with chronic stroke will be significantly lower: 1) during a single bout of HIIT, and 2) during the recovery immediately following and 30 minutes after HIIT, compared to CON. This study has 2 visits at the University of Kansas Medical Center Research in Exercise and Cardiovascular Health Laboratory. For the first visit, we will perform questionnaires about heart health, physical activity and overall health. Participants will then complete a submaximal exercise test on a seated stepper. Participants will also have a familiarization session to practice HIIT. The second visit will include cerebrovascular measures before, during, immediately after, and 30 minutes after performing HIIT.
Interventions
- BEHAVIORAL Single, acute bout of high intensity interval exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2023-02-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04673994
The ClinicalTrials.gov registry entry for NCT04673994 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Single, acute bout of high intensity interval exercise is the first listed.
NCT04673994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04673994 about?
NCT04673994 is a clinical study titled "Blood Flow Response and Acute INterval Exercise". The objective of this project is to study the cerebrovascular response to a single bout of high intensity interval exercise (HIIT) in 25 individuals with chronic stroke compared to 25 age- and sex- matched healthy controls (CON). We will enroll 25 young healthy adults (CONyoung) as a reference group...
What is the current status of trial NCT04673994?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2020-12-09. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT04673994?
The interventions under investigation include: Single, acute bout of high intensity interval exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04673994?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.